These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17122988)

  • 61. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular markers in bladder cancer.
    Shariat SF; Karam JA; Lerner SP
    Curr Opin Urol; 2008 Jan; 18(1):1-8. PubMed ID: 18090481
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
    El Jabbour T; Misyura M; Cowzer D; Zimmermann M; Rimkunas V; Marra A; Derakhshan F; Selenica P; Parilla M; Setton JS; Ceyhan-Birsoy O; Kemel Y; Catchings A; Ranganathan M; Ku GY; Janjigian YY; Zinda M; Koehler M; Stadler Z; Shia J; Reis-Filho JS; Mandelker D
    J Natl Cancer Inst; 2022 May; 114(5):761-770. PubMed ID: 35078243
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular changes in brain tumors: prognostic and therapeutic impact.
    Sanson M; Laigle-Donadey F; Benouaich-Amiel A
    Curr Opin Oncol; 2006 Nov; 18(6):623-30. PubMed ID: 16988585
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?
    Dolan K; Morris AI; Gosney JR; Field JK; Sutton R
    J Gastroenterol Hepatol; 2004 Jan; 19(1):24-30. PubMed ID: 14675239
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Validation of molecular and immunological factors with predictive importance in lung cancer.
    Fischer JR; Lahm H
    Lung Cancer; 2004 Aug; 45 Suppl 2():S151-61. PubMed ID: 15552796
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma.
    Tänzer M; Liebl M; Quante M
    Pharmacol Ther; 2013 Nov; 140(2):133-47. PubMed ID: 23791941
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusion.
    Zhang W; Williams TA; Bhagwath AS; Hiermann JS; Peacock CD; Watkins DN; Ding P; Park JY; Montgomery EA; Forastiere AA; Jie C; Cantarel BL; Pham TH; Wang DH
    Lab Invest; 2020 Jan; 100(1):16-26. PubMed ID: 31292541
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection of a Novel
    Ferrari A; Fiocca R; Bonora E; Domizio C; Fonzi E; Angeli D; Domenico Raulli G; Mattioli S; Martinelli G; Molinari C
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107676
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genomic and transcriptomic alterations associated with drug vulnerabilities and prognosis in adenocarcinoma at the gastroesophageal junction.
    Lin Y; Luo Y; Sun Y; Guo W; Zhao X; Xi Y; Ma Y; Shao M; Tan W; Gao G; Wu C; Lin D
    Nat Commun; 2020 Nov; 11(1):6091. PubMed ID: 33257699
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gastroesophageal Junction Adenocarcinoma With Skeletal Muscle Metastases: A Case Report and Literature Review.
    Sabu J; Thida AM; Seong G; Mohiuddin A; Attia H; Agaronov M; Chiu E
    Cureus; 2024 Jul; 16(7):e63855. PubMed ID: 39099909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genes Regulating Epithelial Polarity Are Critical Suppressors of Esophageal Oncogenesis.
    Li XM; Wang H; Zhu LL; Zhao RZ; Ji HL
    J Cancer; 2015; 6(8):694-700. PubMed ID: 26185530
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Midesophageal Metastatic Disease After Treatment of Gastroesophageal Junction Adenocarcinoma.
    Brotherton T; Burton S; Knoche E; Presti M
    ACG Case Rep J; 2022 Oct; 9(10):e00869. PubMed ID: 36212240
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comment on "High Systemic Immune-inflammation Index Is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma".
    Sun L; Liang H; Feng Y
    Ann Surg; 2021 Dec; 274(6):e668-e669. PubMed ID: 31688272
    [No Abstract]   [Full Text] [Related]  

  • 75. Response to the Comment on "High Systemic Immune-inflammation Index Is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma".
    Schoppmann SF; Jomrich G
    Ann Surg; 2021 Dec; 274(6):e669-e670. PubMed ID: 31688274
    [No Abstract]   [Full Text] [Related]  

  • 76. [Prognostic significance of cyclooxygenase 2 expression in adenocarcinoma of the esophagus].
    Schrader H; Schmidt WE
    Z Gastroenterol; 2003 Jul; 41(7):679-81. PubMed ID: 16299956
    [No Abstract]   [Full Text] [Related]  

  • 77. Pathologic Features of Esophageal and Gastric Malignancies.
    Al-Nattah S; Matkovic E; Schwalbe M; Matkowskyj KA
    Cancer Treat Res; 2024; 192():19-48. PubMed ID: 39212914
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development and Validation of a Prognostic Model for Postoperative Anastomotic Recurrence in Siewert II or III Adenocarcinomas Without Neoadjuvant Therapy in an East Asian Population.
    Huang MB; Xu C; Chen H; Lin JX; Zheng CH; Chen QX; Lian MQ; Lian MJ; Lv CB; Yang SB; Cai LS; Huang CM; Xue FQ
    J Gastrointest Cancer; 2024 Jun; 55(2):702-713. PubMed ID: 38175384
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study.
    Liu X; Jiang Q; Yue C; Wang Q
    Int J Gen Med; 2021; 14():10303-10314. PubMed ID: 34992445
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Obesity Potentiates Esophageal Squamous Cell Carcinoma Growth and Invasion by AMPK-YAP Pathway.
    Liu JH; Wu QF; Fu JK; Che XM; Li HJ
    J Immunol Res; 2020; 2020():6765474. PubMed ID: 33381605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.